Evidence map›Paper›PMID 26617917›Full record

ArticleInternational journal of clinical and experimental pathology2015

Synchronous primary breast cancer and hepatocellular carcinoma in a male patient: a case report.

Fei Tian, Xiuzheng Cui, Lin Li, Haizhen Lu, Weiqi Rong, Chao Bi, Jianxiong Wu

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fei TianCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Xiuzheng CuiCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Lin LiCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Haizhen LuCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Weiqi RongCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Chao BiCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Jianxiong WuCancer Institute and Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing 100021, People's Republic of China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Male breast cancer is a rare malignant disease characterized by hormonal imbalance. Hepatocellular carcinoma (HCC) is the most common neoplasm of the liver, and is generally correlated with hepatitis B or C virus-related cirrhosis. While to our knowledge a case with these two malignant diseases in a same male patient in the concomitant period is an exceptional event, rarely reported in literature. In this report, we present a case in which a Chinese patient with hepatitis B developed a tumor mass that originated from segment V of the liver and presented with right breast nodules at the same time. Synchronous mastectomy and hepatectomy were performed, and standard endocrine therapy and chemotherapy as adjuvant treatment were therefore followed. The diverse histogenesis of the two kinds of cancers highlights the need for us to investigate any common physiopathogenetic elements.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBreast Neoplasms, MaleCarcinoma, Ductal, BreastCarcinoma, HepatocellularHepatitis BHumansImmunohistochemistryLiver NeoplasmsMaleMiddle AgedNeoplasms, Multiple PrimaryBiomarkers, Tumorhepatocellular carcinomaMale breast cancersynchronous resection

Identifiers

PMID26617917
PMCPMC4637733
OpenAlexW2181561377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.